Aarti Drugs Statistics

Total Valuation

Aarti Drugs has a market cap or net worth of INR 31.49 billion. The enterprise value is 37.10 billion.

Market Cap	31.49B
Enterprise Value	37.10B

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	Feb 4, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.87%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	35.72M

Valuation Ratios

The trailing PE ratio is 20.64.

PE Ratio	20.64
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	24.31
EV / Sales	1.59
EV / EBITDA	12.85
EV / EBIT	15.68
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.46
Debt / EBITDA	2.04
Debt / FCF	n/a
Interest Coverage	6.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	8.07%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	21.90M
Profits Per Employee	1.43M
Employee Count	1,064
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.65% in the last 52 weeks. The beta is 0.88, so Aarti Drugs's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	-24.65%
50-Day Moving Average	378.38
200-Day Moving Average	468.52
Relative Strength Index (RSI)	43.40
Average Volume (20 Days)	220,432

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aarti Drugs had revenue of INR 23.30 billion and earned 1.53 billion in profits. Earnings per share was 16.69.

Revenue	23.30B
Gross Profit	8.09B
Operating Income	2.37B
Pretax Income	2.05B
Net Income	1.53B
EBITDA	2.87B
EBIT	2.37B
Earnings Per Share (EPS)	16.69

Full Income Statement

Balance Sheet

The company has 295.60 million in cash and 5.90 billion in debt, giving a net cash position of -5.61 billion.

Cash & Cash Equivalents	295.60M
Total Debt	5.90B
Net Cash	-5.61B
Net Cash Per Share	n/a
Equity (Book Value)	12.78B
Book Value Per Share	139.96
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 34.70%, with operating and profit margins of 10.15% and 6.55%.

Gross Margin	34.70%
Operating Margin	10.15%
Pretax Margin	8.79%
Profit Margin	6.55%
EBITDA Margin	12.30%
EBIT Margin	10.15%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.29%.

Dividend Per Share	1.00
Dividend Yield	0.29%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.87%
Shareholder Yield	1.16%
Earnings Yield	4.85%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on September 30, 2020. It was a forward split with a ratio of 4.

Last Split Date	Sep 30, 2020
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a